Evidence map›Paper›PMID 20122999›Full record

ArticleNeuroscience2010

Alpha-2 noradrenergic receptor activation inhibits the hyperpolarization-activated cation current (Ih) in neurons of the ventral tegmental area.

M U Inyushin, F Arencibia-Albite, R Vázquez-Torres, M E Vélez-Hernández, C A Jiménez-Rivera

Abstract read
In one paragraph

Article in Neuroscience, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Effect of αBulletin of experimental biology and medicine · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. HCN Channel Targets for Novel Antidepressant Treatment.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  7. Addictive neurons.Therapeutic targets for neurological diseases · 2017
    Article
  8. Review
  9. HCN Channels Modulators: The Need for Selectivity.Current topics in medicinal chemistry · 2016
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M U InyushinDepartment of Physiology, Universidad Central del Caribe, Medical School, PO Box 60-327, Bayamón, Puerto Rico.
F Arencibia-Albite
R Vázquez-Torres
M E Vélez-Hernández
C A Jiménez-Rivera
University of Puerto Rico, Medical Sciences Campus · PR

Funding

UPR--MEDICAL SCIENCES CAMPUS, MBRS PROGRAMS06GM008224 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI SILVA, WALTER I · 1989 to 2008
$28.0M
RISE Option III: MBRS RISE at the UPR Medical Sciences CampusR25GM061838 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI CADILLA, CARMEN LYDIA · 2000 to 2021
$25.5M
PKMzeta involvement in cocaine sensitizationSC1GM084854 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI JIMENEZ-RIVERA, CARLOS A · 2008 to 2016
$2.4M
NIGMS NIH HHS 1SC1GM084854-01NIGMS NIH HHS GM-08224NIGMS NIH HHS R25 GM061838NIGMS NIH HHS R25-GM061838NIGMS NIH HHS S06 GM008224NIGMS NIH HHS SC1 GM084854
6 · The paper itself

Abstract

The ventral tegmental area (VTA) is the source of dopaminergic projections innervating cortical structures and ventral forebrain. Dysfunction of this mesocorticolimbic system is critically involved in psychiatric disorders such as addiction and schizophrenia. Changes in VTA dopamine (DA) neuronal activity can alter neurotransmitter release at target regions which modify information processing in the reward circuit. Here we studied the effect of alpha-2 noradrenergic receptor activation on the hyperpolarization-activated cation current (I(h)) in DA neurons of the rat VTA. Brain slice preparations using whole-cell current and voltage-clamp techniques were employed. Clonidine and UK14304 (alpha-2 receptor selective agonists) were found to decrease I(h) amplitude and to slow its rate of activation indicating a negative shift in the current's voltage dependence. Two non-subtype-selective alpha-2 receptor antagonists, yohimbine and RS79948, prevented the effects of alpha-2 receptor activation. RX821002, a noradrenergic antagonist specific for alpha-2A and alpha-2D did not prevent I(h) inhibition. This result suggests that clonidine might be acting via an alpha-2C subtype since this receptor is the most abundant variant in the VTA. Analysis of a second messenger system associated with the alpha-2 receptor revealed that I(h) inhibition is independent of cyclic AMP (cAMP) and resulted from the activation of protein kinase C. It is suggested that the alpha-2 mediated hyperpolarizing shift in I(h) voltage dependence can facilitate the transition from pacemaker firing to afferent-driven burst activity. This transition may play a key role on the changes in synaptic plasticity that occurs in the mesocorticolimbic system under pathological conditions.

Indexed as

Adrenergic alpha-2 Receptor AgonistsAction PotentialsAnimalsCalciumClonidineCyclic AMPCyclic Nucleotide-Gated Cation ChannelsDopamineFemaleHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIn Vitro TechniquesMaleNeuronsPotassium ChannelsProtein Kinase CRatsAdrenergic alpha-2 Receptor AgonistsCalciumClonidineCyclic AMPCyclic Nucleotide-Gated Cation ChannelsDopamineHyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsPotassium ChannelsProtein Kinase C

Identifiers

PMID20122999
PMCPMC2854519
OpenAlexW2141027531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.